Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-01 Russo Rene PRESIDENT AND CEO Exercise or conversion +44,250 325,422
2026-01-01 Russo Rene PRESIDENT AND CEO Exercise or conversion · Restricted Stock Units −44,250 88,500
2025-12-31 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +1,500,258 1,500,258
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +2,075,000 2,075,000
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −239,703 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +239,703 239,703
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −473,334 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +473,334 473,334
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −135,134 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +135,134 135,134
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −50,041 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +50,041 50,041
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −100,000 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +100,000 100,000
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −150,000 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +150,000 150,000
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −350,000 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +350,000 350,000
2025-11-21 Russo Rene PRESIDENT AND CEO Returned to the company · Stock Option (right to buy) −700,000 0
2025-11-21 Russo Rene PRESIDENT AND CEO Grant or award · Stock Option (right to buy) +700,000 700,000

Page 1 of 2 · 33 trades